Scandinavian Real Heart AB (Publ) (FRA:7820)

Market Cap	14.57M +89.4%
Revenue (ttm)	13.47K +61.2%
Net Income	-3.69M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.550
Previous Close	1.600
Day's Range	1.550 - 1.550
52-Week Range	1.095 - 2.540
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About FRA:7820

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7820

Financial Performance

In 2025, FRA:7820's revenue was 153,098, an increase of 7832.54% compared to the previous year's 1,930. Losses were -35.50 million, 3.34% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error